Congress trades
Veracyte, Inc. (VCYT)
Free on iOS and Android.
About Veracyte, Inc.
from the company's filings and listing, as of Oct 20, 2026- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Chief executive
- Marc Stapley
- Employees
- 755
- Listed since
- Oct 29, 2013
- Market value
- $3.5B
- Price to earnings (12 mo)
- 30.4
- Net income per share, as reported (12 mo)
- $1.44
- Dividend yield
- -
Earnings
6 reported quarters · next on Nov 4, 2026| Quarter | EPS | EPS expected | Revenue | Revenue expected | Result |
|---|---|---|---|---|---|
| Q2 FY2026reported Jul 30, 2026 | $0.54 | $0.41 | $150.3M | $144.6M | EPS beatRevenue beat |
| Q1 FY2026reported May 5, 2026 | $0.52 | $0.34 | $139.1M | $130.4M | EPS beatRevenue beat |
| Q4 FY2025reported Feb 25, 2026 | $0.53 | $0.41 | $140.6M | $135.8M | EPS beatRevenue beat |
| Q3 FY2025reported Nov 4, 2025 | $0.51 | $0.32 | $131.9M | $125.0M | EPS beatRevenue beat |
| Q2 FY2025reported Aug 6, 2025 | $0.44 | $0.31 | $130.2M | $121.0M | EPS beatRevenue beat |
| Q1 FY2025reported May 7, 2025 | $0.31 | $0.12 | $114.5M | $111.3M | EPS beatRevenue beat |
Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag reads n/a only when a number is missing. Quarterly EPS is the figure set against the consensus, usually adjusted, so the quarters need not add up to the 12-month net income per share above. An estimate is a forecast made by analysts, not a company target.
Executive pay
as filed for fiscal 2025 · proxy filed Apr 22, 2026| Executive | Salary | Stock awards | Other | Total |
|---|---|---|---|---|
| Marc StapleyChief Executive Officer | $700K | $5.9M | $831K | $7.4M |
| John LeiteGlobal Chief Commercial Officer | $510K | $2.4M | $336K | $3.2M |
| Rebecca ChambersChief Financial Officer | $550K | $2.0M | $362K | $2.9M |
| Annie McGuireGeneral Counsel and Head of Market Access | $500K | $2.0M | $330K | $2.8M |
| Phillip FebboChief Scientific Officer and Chief Medical Officer | $561K | $1.6M | $369K | $2.5M |
The summary compensation table from the proxy statement for fiscal 2025, with titles as filed then. Executives who have since left are not shown. Read the filing
Institutional holders
13F positions as of Jun 30, 2026| Holder | Value | Shares | Shares vs prior qtr | % of shares out |
|---|---|---|---|---|
| BlackRock, Inc. | $792.1M | 13,486,437 | +2.4% | 16.93% |
| FMR LLC | $452.4M | 7,702,746 | -0.8% | 9.67% |
| Artisan Partners Limited Partnership | $325.3M | 5,538,404 | +0.8% | 6.95% |
| Vanguard Portfolio Management LLC | $277.0M | 4,716,191 | +6.1% | 5.92% |
| State Street Corp | $276.0M | 4,698,128 | -6.8% | 5.91% |
| Vanguard Capital Management LLC | $211.1M | 3,593,922 | +1.7% | 4.51% |
| Dimensional Fund Advisors LP | $166.0M | 2,826,524 | -1.9% | 3.55% |
| First Trust Advisors LP | $147.3M | 2,507,902 | +18.5% | 3.15% |
| ARK Investment Management LLCCathie Wood | $134.8M | 2,295,951 | -24.8% | 2.88% |
| Wellington Management Group LLP | $133.6M | 2,274,160 | -11.1% | 2.85% |
| Geode Capital Management, LLC | $123.6M | 2,104,000 | +7.5% | 2.64% |
| Goldman Sachs Group Inc | $96.5M | 1,642,911 | +28.7% | 2.06% |
A 13F reports long US equity positions and is filed within 45 days of the quarter end, so these are positions as they stood on Jun 30, 2026. For a manager's whole book see the fund directory. What a 13F covers and leaves out is explained in our guide to Form 13F.
GetSignal watches Form 4 and STOCK Act filings and pushes each one to your phone as it is published, with the history behind it. Free on iOS and Android.
Congress trades in VCYT
14 disclosures of 14 on record · median 30d of the 45 allowedSince the trade: the stock's move from the trade date to the latest close we hold (figures as of Oct 24, 2026), not the member's result. Not investment advice.
| Member | Type | Action | Amount disclosed | Stock since the trade | Trade date | Disclosed | Delay |
|---|---|---|---|---|---|---|---|
| Gilbert Ray Cisneros, Jr. | Stock | Purchase | $1,001 - $15,000 | +36.6%S&P 500 +11.6% · +25.0 pts vs S&P 500 | Mar 3, 2026 | Apr 7, 2026 | 35d |
| Gilbert Ray Cisneros, Jr. | Stock | Sale | $1,001 - $15,000 | +13.3%After the saleS&P 500 +11.2% · +2.1 pts vs S&P 500 | Nov 12, 2025 | Dec 15, 2025 | 33d |
| Gilbert Ray Cisneros, Jr. | Stock | Purchase | $1,001 - $15,000 | +79.9%S&P 500 +26.1% · +53.8 pts vs S&P 500 | Jun 16, 2025 | Jul 10, 2025 | 24d |
| Josh GottheimerJoint | Stock | Purchase | $1,001 - $15,000 | +125.2%S&P 500 +74.4% · +50.8 pts vs S&P 500 | Oct 16, 2023 | Nov 11, 2023 | 26d |
| Josh GottheimerJoint | Stock | Sale | $1,001 - $15,000 | +91.3%After the saleS&P 500 +70.9% · +20.4 pts vs S&P 500 | Sep 15, 2023 | Oct 15, 2023 | 30d |
| Daniel S. Goldman | Stock | Sale | $1,001 - $15,000 | +125.0%After the saleS&P 500 +85.6% · +39.4 pts vs S&P 500 | Apr 10, 2023 | May 19, 2023 | 39d |
| Gilbert Ray Cisneros, Jr. | Stock | Sale | $1,001 - $15,000 | -16.1%After the saleS&P 500 +107.3% · -123.4 pts vs S&P 500 | Dec 10, 2020 | Jan 11, 2021 | 32d |
| Gilbert Ray Cisneros, Jr. | Stock | Sale | $1,001 - $15,000 | -15.9%After the saleS&P 500 +106.8% · -122.7 pts vs S&P 500 | Dec 23, 2020 | Jan 11, 2021 | 19d |
| Josh GottheimerJoint | Stock | Sale | $1,001 - $15,000 | -20.5%After the saleS&P 500 +105.4% · -125.9 pts vs S&P 500 | Dec 8, 2020 | Jan 7, 2021 | 30d |
| Gilbert Ray Cisneros, Jr. | Stock | Sale | $1,001 - $15,000 | +30.2%After the saleS&P 500 +130.4% · -100.2 pts vs S&P 500 | Oct 29, 2020 | Nov 5, 2020 | 7d |
| Gilbert Ray Cisneros, Jr. | Stock | Purchase | $1,001 - $15,000 | +59.0%S&P 500 +129.0% · -70.0 pts vs S&P 500 | Jan 17, 2020 | Feb 18, 2020 | 32d |
| Gilbert Ray Cisneros, Jr. | Stock | Purchase | $1,001 - $15,000 | +67.4%S&P 500 +139.8% · -72.4 pts vs S&P 500 | Dec 12, 2019 | Jan 10, 2020 | 29d |
| Gilbert Ray Cisneros, Jr. | Stock | Purchase | $1,001 - $15,000 | +61.9%S&P 500 +136.7% · -74.7 pts vs S&P 500 | Dec 24, 2019 | Jan 10, 2020 | 17d |
| Josh GottheimerJoint | Stock | Purchase | $1,001 - $15,000 | +64.3%S&P 500 +141.6% · -77.3 pts vs S&P 500 | Dec 6, 2019 | Jan 6, 2020 | 31d |
Since the trade is an estimate, set beside the S&P 500 over the same window, with the gap between the two in percentage points. The filing carries a band, not a fill, and a sale keeps the stock's sign, so a positive figure after a sale means the stock kept rising after it. An option row carries the underlying stock's move. A row marked n/a is one we hold no figure for.
A delay above 45 days is the gap between the dates on the report; we mark a filing late only after checking it.
"Not captured" means the band or the transaction type on the original report is missing from our data.
"Dates conflict" marks a row whose disclosure is dated before its trade on the record we hold. Both dates are printed as filed, and no since-the-trade figure is computed from them.
Every Congress trade in VCYT, filterable by party, chamber, type and account.
Members of Congress reporting a position
2 members · estimate, as of Oct 19, 20262 members report a position (estimated). The largest estimated position is in the $15,001 - $50,000 band.
| Member | Party, chamber | Estimated position | Share of their portfolio |
|---|---|---|---|
| Gilbert Ray Cisneros, Jr. | Democrat · House | $15,001 - $50,000 | 0.1% |
| Josh Gottheimer | Democrat · House | $1,001 - $15,000 | <0.1% |
Estimate, as of Oct 19, 2026. Each position is modelled from the member's disclosed transactions and annual filings: the midpoint of each disclosed band, moved with the stock's price since the trade. It is a rough estimate of a reported position, not a figure from a filing, which is why it is shown as a band. Share of portfolio sets that estimate against the member's whole estimated public-stock portfolio.
Questions
Which members of Congress have traded VCYT?
Gilbert Ray Cisneros, Jr., Josh Gottheimer and Daniel S. Goldman disclosed VCYT transactions in the filings shown here.
Which members of Congress hold VCYT?
2 members of Congress report a position in VCYT in the estimate we hold as of Oct 19, 2026. The estimated positions belong to Gilbert Ray Cisneros, Jr. and Josh Gottheimer. The estimate is built from disclosed transactions and annual filings, so it is shown as a band rather than a figure from a filing.
How quickly are VCYT trades disclosed?
Congressional disclosures took a median of 30 days, against the 45 the STOCK Act allows.
How to read a STOCK Act filing
WHAT THE FILING ACTUALLY SAYS
Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.
Data as of Oct 26, 2026.